# A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

> **NCT00144989** · PHASE3 · COMPLETED · sponsor: **Haruhiko Fukuda** · enrollment: 281 (actual)

## Conditions studied

- Small-Cell-Lung Cancer

## Interventions

- **DRUG:** Etoposide and cisplatin after chemoradiotherapy
- **DRUG:** Irinotecan and cisplatin after chemoradiotherapy

## Key facts

- **NCT ID:** NCT00144989
- **Lead sponsor:** Haruhiko Fukuda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144989, "A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00144989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*